A study on Thaeththuvai chooranam and Varma therapy in the management of thaeththuvai

Effectiveness of thaeththuvai chooranam varma therapy in the management of thaeththuvai (stuttering speech) among pediatric age group - A case series - Nil

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068728

Enrollment

Registered

2024-06-11

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R478- Other speech disturbances

Interventions

Intervention1: Internal medicine _ Thaeththuvai chooranam : Internal medicine: Administrated orally once a day [early morning only]. Dosage [according to age of the patient]. Duration- one month Int

Eligibility

Inclusion criteria

Inclusion criteria: Children with disfluent speech Patients who are willing to involve in the study

Exclusion criteria

Exclusion criteria: Stuttering occured after surgery, Anatomical deformity in vocal cord by birth, Stuttering associated with genetic disorder, Family history of stuttering

Design outcomes

Primary

Measure	Time frame
The outcome will be aimed at reducing the symptoms of thaeththuvai (stuttering speech) and to determine the effectiveness of thaeththuvai chooranam and varma therapyTimepoint: 4month	—

Secondary

Measure	Time frame
nilTimepoint: nil	—

Countries

India

Contacts

Public ContactDR S GEETHA DEVI

Government siddha medical college and hospital, palayamkottai

geethadevis16@yahoo.in7401757475

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026